STAT

Opinion: ‘Neglected diseases’ are anything but neglected by the billion-plus people living with them

The wide variety of "neglected diseases" means there is no face, no poster child, to excite the sympathy of donors. These diseases must find a voice to attract leadership, advocacy,…
Group A streptococcus kills 500,000 people a year.

I dislike the term “neglected tropical diseases.” This collection of communicable diseases is neglected — a pejorative term — only by countries unaffected by them. They aren’t neglected by the 1 billion or more individuals afflicted with them, the millions who die from them, or the countries in which they live.

The World Health Organization as “neglected.” Gaining consensus around what constitutes these diseases is as difficult as pronouncing dracunculiasis, schistosomiasis, or chromoblastomycosis. What’s more, there are diseases that kill tens or hundreds of thousands of people every year that don’t make the list, like hepatitis E, which kills 70,000 pregnant women a year, and group A streptococcus (the cause of strep

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks